319 related articles for article (PubMed ID: 28603775)
1. CRISPR/Cas9: From Genome Engineering to Cancer Drug Discovery.
Luo J
Trends Cancer; 2016 Jun; 2(6):313-324. PubMed ID: 28603775
[TBL] [Abstract][Full Text] [Related]
2. A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way?
Taylor J; Woodcock S
J Biomol Screen; 2015 Sep; 20(8):1040-51. PubMed ID: 26048892
[TBL] [Abstract][Full Text] [Related]
3. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery.
Ahmad G; Amiji M
Drug Discov Today; 2018 Mar; 23(3):519-533. PubMed ID: 29326075
[TBL] [Abstract][Full Text] [Related]
4. Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference.
Barrangou R; Birmingham A; Wiemann S; Beijersbergen RL; Hornung V; Smith Av
Nucleic Acids Res; 2015 Apr; 43(7):3407-19. PubMed ID: 25800748
[TBL] [Abstract][Full Text] [Related]
5. The role of the CRISPR-Cas system in cancer drug development: Mechanisms of action and therapy.
Chandrasekaran AP; Karapurkar JK; Chung HY; Ramakrishna S
Biotechnol J; 2022 Jul; 17(7):e2100468. PubMed ID: 35157790
[TBL] [Abstract][Full Text] [Related]
6. [CRISPR/Cas systems in genome engineering of bacteriophages].
Liang CJ; Meng FM; Ai YC
Yi Chuan; 2018 May; 40(5):378-389. PubMed ID: 29785946
[TBL] [Abstract][Full Text] [Related]
7. Harnessing CRISPR-Cas systems for bacterial genome editing.
Selle K; Barrangou R
Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
[TBL] [Abstract][Full Text] [Related]
8. RNA-guided CRISPR-Cas technologies for genome-scale investigation of disease processes.
Humphrey SE; Kasinski AL
J Hematol Oncol; 2015 Apr; 8():31. PubMed ID: 25888285
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9 Immune System as a Tool for Genome Engineering.
Hryhorowicz M; Lipiński D; Zeyland J; Słomski R
Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):233-240. PubMed ID: 27699445
[TBL] [Abstract][Full Text] [Related]
10. Current and future prospects for CRISPR-based tools in bacteria.
Luo ML; Leenay RT; Beisel CL
Biotechnol Bioeng; 2016 May; 113(5):930-43. PubMed ID: 26460902
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas: From the Bacterial Adaptive Immune System to a Versatile Tool for Genome Engineering.
Kirchner M; Schneider S
Angew Chem Int Ed Engl; 2015 Nov; 54(46):13508-14. PubMed ID: 26382836
[TBL] [Abstract][Full Text] [Related]
12. RNA Interference in the Age of CRISPR: Will CRISPR Interfere with RNAi?
Unniyampurath U; Pilankatta R; Krishnan MN
Int J Mol Sci; 2016 Feb; 17(3):291. PubMed ID: 26927085
[TBL] [Abstract][Full Text] [Related]
13. CRISPR-Cas9 and CRISPR-Assisted Cytidine Deaminase Enable Precise and Efficient Genome Editing in Klebsiella pneumoniae.
Wang Y; Wang S; Chen W; Song L; Zhang Y; Shen Z; Yu F; Li M; Ji Q
Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217854
[No Abstract] [Full Text] [Related]
14. Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.
Bruder MR; Pyne ME; Moo-Young M; Chung DA; Chou CP
Appl Environ Microbiol; 2016 Oct; 82(20):6109-6119. PubMed ID: 27496775
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9-mediated genome engineering of CHO cell factories: Application and perspectives.
Lee JS; Grav LM; Lewis NE; Faustrup Kildegaard H
Biotechnol J; 2015 Jul; 10(7):979-94. PubMed ID: 26058577
[TBL] [Abstract][Full Text] [Related]
16. Applications of CRISPR-Cas systems in neuroscience.
Heidenreich M; Zhang F
Nat Rev Neurosci; 2016 Jan; 17(1):36-44. PubMed ID: 26656253
[TBL] [Abstract][Full Text] [Related]
17. The New State of the Art: Cas9 for Gene Activation and Repression.
La Russa MF; Qi LS
Mol Cell Biol; 2015 Nov; 35(22):3800-9. PubMed ID: 26370509
[TBL] [Abstract][Full Text] [Related]
18. [Application Progress of CRISPR/Cas9 System for Gene Editing in Tumor Research].
Liu C; Li Z; Zhang Y
Zhongguo Fei Ai Za Zhi; 2015 Sep; 18(9):571-9. PubMed ID: 26383982
[TBL] [Abstract][Full Text] [Related]
19. [The application of CRISPR/Cas9 genome editing technology in cancer research].
Wang DY; Ma N; Hui Y; Gao X
Yi Chuan; 2016 Jan; 38(1):1-8. PubMed ID: 26787518
[TBL] [Abstract][Full Text] [Related]
20. Genome engineering in ophthalmology: Application of CRISPR/Cas to the treatment of eye disease.
Hung SSC; McCaughey T; Swann O; Pébay A; Hewitt AW
Prog Retin Eye Res; 2016 Jul; 53():1-20. PubMed ID: 27181583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
